Skip to content

FINCH THERAPEUTICS GROUP, INC.

CIK 0001733257

← back to feed
Revenue (TTM)
$0
−87.6% YoY Q2 Aug 2024
Net Income (TTM)
−$18.08M
+34.8% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$11.26
+35.4% YoY Q2 Aug 2024
Gross Margin
—
Q2 Aug 2024
Operating Margin
—
Q2 Aug 2024
Net Margin
—
Q2 Aug 2024
Free Cash Flow (TTM)
−$68.36M
Q2 Aug 2024
Cash
$16.04M
Q2 Aug 2024
Total Debt
$0
Q2 Aug 2024
Shares Outstanding
1.61M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings